No ACS approvals for rivaroxaban, Janssen announces

As expected, the Food and Drug Administration has declined to approve the oral anticoagulant rivaroxaban for treating acute coronary syndromes. The manufacturer of the factor Xa inhibitor, Janssen...

Field of Interest: Cardiology
Type: News Item

Sepsis less common, less deadly in pregnancy

SAN FRANCISCO – The incidence of severe sepsis was nearly five times lower and the risk of death from severe sepsis was 43% lower during pregnancy, compared with nonpregnant women, in a large...

Field of Interest: Infectious diseases
Type: News Item

Mini-VADs could transform heart failure therapy

SNOWMASS, COLO. – Survival in patients with advanced heart failure who receive a left ventricular assist device as destination therapy or as a bridge to transplant has increased dramatically in...

Field of Interest: Cardiology
Type: News Item

New stroke guidelines focus on women’s risks

Newly released guidelines provide the first evidence-based recommendations for preventing stroke in women. The document addresses the issues that uniquely increase stroke risk in women – pregnancy,...

Field of Interest: Cardiology
Type: News Item

CoreValve holds size advantage for U.S. TAVR

When the Food and Drug Administration in January granted marketing approval to a second transcatheter aortic valve replacement system for inoperable patients with aortic stenosis, the CoreValve...

Field of Interest: Cardiology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness